LGI1 and epilepsy: Furthermore, enhancing the interaction between the LGI1-ADAM22 complex and PSD-95 family proteins may prevent epilepsy [26–29], and restoring Kv1 activity using celecoxib, a drug approved by the Food and Drug Administration, ameliorates seizure susceptibility in global LGI1 knockout mice [18].